Experts gathered at the webinar 'Profit-sharing and biosimilars: from theory to practice', organized by the Spanish Association of Biosimilar Medicines (BioSim), have described the implementation of profit-sharing programs with biosimilar medicines in Spain as 'highly feasible'.